Table 3: Medications for the treatment of pulmonary arterial hypertension.
Pharmacological group |
Medication
|
Dose |
Phosphodiesterase 5 inhibitors |
Sildenafil
Tadalafilo
|
20 mg/8 h
20 mg/24 h |
Endothelin receptor antagonists |
Bosentan Ambrisentan Macitentan
|
125 mg/12 h 10 mg/12 h 10 mg/12 h |
Prostacyclin analogues and IP receptor agonists |
Selexipag
Iloprosts inhaled
Intravenous Epoprostenol |
200-1.600 mcg/12 h Start 200 mcg 2/12 h, increase of 200 mcg 12/h, with intervals of 1 week between doses. Maximum dose 1,600 mcg/12 h
2.5 - 56 mcg/inhaled/6-9 times daily
20-40 ng/kg/min |
Guanylate cyclase stimulators |
Riociguat |
1 mg 3/8 h for 2 weeks. Increase in increments of 0.5 mg/8 h every 2 weeks to a maximum of 2.5 mg/8 h |